This is a table of type noun and their frequencies. Use it to search & browse the list to learn more about your study carrel.
noun | frequency |
---|---|
patients | 17384 |
cells | 8988 |
cell | 7634 |
disease | 4417 |
results | 3947 |
treatment | 3834 |
patient | 3228 |
years | 3194 |
study | 3030 |
infection | 2707 |
group | 2670 |
cases | 2665 |
expression | 2654 |
age | 2645 |
therapy | 2506 |
transplantation | 2474 |
months | 2380 |
days | 2356 |
risk | 2334 |
transplant | 2184 |
blood | 2117 |
virus | 2112 |
diagnosis | 2063 |
analysis | 2058 |
time | 2030 |
infections | 1976 |
stem | 1966 |
donor | 1961 |
children | 1941 |
response | 1902 |
day | 1881 |
levels | 1799 |
survival | 1774 |
data | 1762 |
methods | 1521 |
tumor | 1495 |
case | 1489 |
method | 1414 |
conclusion | 1403 |
gene | 1351 |
protein | 1287 |
range | 1286 |
conditioning | 1278 |
dose | 1277 |
graft | 1245 |
studies | 1234 |
activity | 1227 |
role | 1225 |
pts | 1199 |
syndrome | 1189 |
number | 1130 |
grade | 1130 |
incidence | 1114 |
bone | 1110 |
function | 1101 |
relapse | 1089 |
groups | 1061 |
marrow | 1053 |
type | 1030 |
year | 1029 |
cancer | 1027 |
use | 1008 |
conclusions | 1000 |
mortality | 990 |
lymphoma | 986 |
mice | 964 |
donors | 955 |
prophylaxis | 923 |
development | 922 |
activation | 919 |
level | 912 |
factors | 910 |
effect | 905 |
mutations | 901 |
regimen | 897 |
control | 896 |
chemotherapy | 884 |
disclosure | 872 |
rate | 866 |
mutation | 849 |
failure | 846 |
effects | 842 |
follow | 841 |
system | 833 |
leukemia | 822 |
background | 810 |
deficiency | 810 |
antibodies | 805 |
serum | 803 |
factor | 797 |
tumors | 793 |
complications | 785 |
symptoms | 774 |
host | 771 |
recipients | 767 |
antibody | 762 |
samples | 761 |
presence | 751 |
population | 750 |
outcome | 748 |
outcomes | 744 |
antigen | 737 |
diseases | 736 |
responses | 731 |
liver | 723 |
allo | 722 |
cohort | 719 |
proliferation | 716 |
none | 702 |
immunodeficiency | 699 |
receptor | 698 |
period | 698 |
lung | 687 |
history | 682 |
tissue | 681 |
status | 677 |
findings | 672 |
post | 656 |
objectives | 653 |
median | 650 |
skin | 647 |
lymphocytes | 644 |
interest | 642 |
dna | 641 |
engraftment | 636 |
carcinoma | 636 |
genes | 631 |
evaluation | 626 |
ml | 619 |
life | 614 |
addition | 613 |
weeks | 610 |
production | 608 |
proteins | 606 |
biopsy | 582 |
reactivation | 575 |
presentation | 563 |
care | 556 |
model | 553 |
induction | 553 |
progression | 552 |
family | 552 |
term | 551 |
stage | 548 |
increase | 545 |
features | 543 |
allogeneic | 543 |
lesions | 542 |
remission | 540 |
lymphocyte | 534 |
death | 529 |
conflict | 526 |
fever | 523 |
differences | 521 |
platelet | 520 |
rates | 517 |
objective | 514 |
count | 512 |
impact | 508 |
flow | 508 |
assay | 506 |
test | 504 |
difference | 499 |
loss | 497 |
evidence | 492 |
toxicity | 491 |
plasma | 489 |
pain | 487 |
kidney | 485 |
vaccine | 482 |
adult | 480 |
criteria | 480 |
kg | 475 |
disorders | 463 |
viruses | 461 |
management | 461 |
efficacy | 461 |
frequency | 459 |
line | 452 |
center | 451 |
changes | 451 |
phenotype | 449 |
correlation | 449 |
malignancies | 448 |
controls | 445 |
recovery | 444 |
pathway | 444 |
association | 443 |
sequencing | 440 |
growth | 439 |
cytokine | 438 |
chimerism | 438 |
characteristics | 437 |
cause | 436 |
sclerosis | 434 |
inflammation | 434 |
onset | 426 |
combination | 425 |
weight | 423 |
total | 420 |
testing | 417 |
regimens | 416 |
lines | 415 |
× | 411 |
stimulation | 411 |
phase | 410 |
laboratory | 409 |
cytometry | 409 |
infusion | 407 |
course | 405 |
breast | 405 |
aim | 405 |
anemia | 404 |
detection | 396 |
improvement | 394 |
ratio | 393 |
individuals | 393 |
review | 390 |
administration | 389 |
lymph | 388 |
immunity | 388 |
pneumonia | 386 |
events | 384 |
variant | 382 |
organ | 381 |
protocol | 381 |
apoptosis | 374 |
order | 370 |
examination | 370 |
hospital | 368 |
neutrophil | 365 |
differentiation | 364 |
value | 362 |
score | 362 |
experience | 361 |
hct | 360 |
doses | 360 |
prognosis | 359 |
process | 358 |
culture | 357 |
target | 357 |
source | 356 |
markers | 355 |
approach | 354 |
design | 353 |
memory | 352 |
intensity | 352 |
drug | 352 |
surface | 351 |
involvement | 351 |
recipient | 350 |
replication | 348 |
mechanism | 345 |
majority | 344 |
reduction | 343 |
agents | 342 |
cytokines | 341 |
inhibition | 340 |
subjects | 337 |
complication | 337 |
vivo | 336 |
absence | 336 |
mechanisms | 333 |
immunoglobulin | 333 |
episodes | 332 |
report | 329 |
disorder | 328 |
variants | 326 |
safety | 326 |
malignancy | 326 |
adults | 321 |
prevalence | 317 |
mass | 316 |
research | 316 |
vaccination | 314 |
igg | 314 |
screening | 314 |
month | 314 |
regulation | 313 |
macrophages | 312 |
membrane | 311 |
male | 311 |
conditions | 311 |
duration | 310 |
neutropenia | 308 |
body | 305 |
antigens | 305 |
values | 303 |
series | 303 |
cord | 303 |
acid | 302 |
setting | 301 |
significance | 301 |
quality | 300 |
mobilization | 300 |
health | 296 |
sibling | 295 |
molecules | 295 |
inhibitor | 295 |
parents | 294 |
nothing | 294 |
introduction | 294 |
site | 292 |
literature | 292 |
inhibitors | 292 |
procedure | 290 |
pattern | 290 |
parameters | 290 |
assays | 288 |
tract | 288 |
dl | 286 |
cycle | 286 |
transfusion | 286 |
exposure | 286 |
reaction | 285 |
manifestations | 283 |
immunosuppression | 282 |
numbers | 280 |
table | 279 |
strategy | 279 |
receptors | 278 |
subsets | 277 |
co | 276 |
class | 276 |
auto | 275 |
part | 274 |
types | 274 |
release | 273 |
hepatitis | 272 |
reconstitution | 271 |
trial | 270 |
biopsies | 269 |
abnormalities | 269 |
infants | 268 |
work | 267 |
influenza | 267 |
generation | 267 |
brain | 266 |
week | 264 |
therapies | 264 |
contrast | 264 |
size | 263 |
transplants | 263 |
end | 262 |
peptide | 262 |
severity | 261 |
myeloma | 261 |
gvhd | 260 |
agvhd | 256 |
reports | 255 |
mouse | 255 |
index | 255 |
hours | 255 |
comparison | 255 |
percentage | 254 |
cm | 254 |
transcription | 253 |
information | 252 |
counts | 251 |
marker | 249 |
steroid | 249 |
expansion | 248 |
decrease | 248 |
potential | 247 |
morbidity | 247 |
strategies | 246 |
analyses | 246 |
option | 245 |
need | 245 |
tests | 243 |
ability | 242 |
region | 241 |
concentration | 241 |
female | 240 |
admission | 240 |
lack | 240 |
pathogenesis | 240 |
lesion | 239 |
sarcoma | 238 |
tumour | 237 |
myeloid | 237 |
depletion | 237 |
child | 236 |
form | 235 |
signs | 235 |
result | 234 |
models | 234 |
collection | 234 |
dysfunction | 233 |
cultures | 233 |
pathways | 232 |
formation | 232 |
selection | 231 |
injury | 230 |
carcinomas | 230 |
urine | 229 |
tissues | 229 |
busulfan | 229 |
steroids | 228 |
genome | 228 |
capacity | 228 |
childhood | 226 |
times | 226 |
rejection | 226 |
node | 225 |
defects | 225 |
assessment | 225 |
lymphomas | 224 |
drugs | 224 |
support | 223 |
thrombocytopenia | 223 |
populations | 222 |
males | 222 |
staining | 221 |
females | 220 |
profile | 219 |
replacement | 218 |
products | 218 |
antibiotics | 218 |
sample | 217 |
identification | 217 |
neutrophils | 216 |
surgery | 215 |
peptides | 215 |
specimens | 213 |
mg | 213 |
interactions | 212 |
agent | 212 |
institution | 212 |
os | 212 |
side | 212 |
event | 211 |
chain | 211 |
resolution | 210 |
monitoring | 210 |
centers | 210 |
cycles | 209 |
women | 208 |
regression | 208 |
initiation | 207 |
sites | 206 |
sequence | 206 |
procedures | 206 |
monocytes | 206 |
maintenance | 205 |
product | 205 |
program | 205 |
relationship | 205 |
interaction | 204 |
grafts | 203 |
date | 203 |
change | 203 |
terms | 202 |
distribution | 202 |
metastasis | 201 |
length | 201 |
damage | 201 |
cyclophosphamide | 201 |
condition | 201 |
importance | 200 |
areas | 200 |
knowledge | 199 |
panel | 199 |
state | 199 |
autoimmunity | 198 |
titers | 195 |
sepsis | 195 |
self | 195 |
nodes | 195 |
authors | 195 |
spectrum | 194 |
sex | 192 |
° | 191 |
susceptibility | 191 |
colitis | 191 |
volume | 190 |
origin | 190 |
causes | 190 |
fibrosis | 189 |
load | 189 |
gamma | 189 |
pathogens | 187 |
positivity | 186 |
area | 185 |
scores | 184 |
outbreak | 184 |
imaging | 184 |
survivors | 183 |
diarrhea | 183 |
ci | 183 |
vitamin | 182 |
binding | 181 |
transfusions | 180 |
functions | 180 |
gender | 179 |
platelets | 179 |
organs | 178 |
trials | 177 |
resistance | 177 |
domain | 177 |
kinase | 176 |
recurrence | 175 |
sensitivity | 174 |
proportion | 174 |
pathology | 174 |
hospitalization | 174 |
iron | 173 |
concentrations | 173 |
alpha | 173 |
cr | 172 |
copies | 172 |
records | 172 |
regions | 172 |
necrosis | 171 |
hemoglobin | 171 |
cgvhd | 171 |
hypertension | 170 |
treatments | 169 |
transfer | 168 |
tool | 167 |
cost | 167 |
bacteria | 167 |
a. | 167 |
secretion | 167 |
metastases | 165 |
fludarabine | 165 |
chest | 165 |
cancers | 165 |
point | 164 |
suppression | 164 |
spleen | 163 |
infusions | 163 |
guidelines | 163 |
adolescents | 163 |
prevention | 162 |
deletion | 162 |
degree | 162 |
specificity | 161 |
others | 161 |
heart | 161 |
adherence | 160 |
maturation | 159 |
defect | 159 |
intervention | 158 |
beta | 158 |
dysregulation | 158 |
participants | 158 |
practice | 158 |
vaccines | 158 |
variables | 157 |
components | 156 |
application | 156 |
invasion | 156 |
fusion | 156 |
infiltration | 155 |
vector | 153 |
unit | 153 |
effector | 153 |
creatinine | 153 |
birth | 153 |
investigation | 153 |
salvage | 152 |
occurrence | 152 |
families | 152 |
calcium | 152 |
cyclosporine | 151 |
promoter | 151 |
forms | 151 |
sequences | 150 |
mud | 150 |
species | 149 |
bladder | 149 |
animals | 149 |
targets | 148 |
p. | 148 |
min | 148 |
interferon | 148 |
injection | 148 |
variety | 147 |
transformation | 146 |
apheresis | 145 |
basis | 145 |
immunohistochemistry | 145 |
stress | 145 |
tolerance | 144 |
phosphorylation | 144 |
rituximab | 143 |
enzyme | 143 |
corticosteroids | 143 |
colon | 143 |
sickle | 142 |
properties | 142 |
hr | 142 |
baseline | 142 |
allograft | 142 |
clones | 141 |
exome | 141 |
experiments | 141 |
radiation | 141 |
recognition | 141 |
stages | 141 |
tuberculosis | 141 |
reactions | 141 |
viremia | 140 |
oncology | 140 |
ligand | 140 |
mscs | 139 |
kit | 139 |
proteinuria | 138 |
component | 138 |
understanding | 137 |
points | 137 |
haplo | 137 |
clinic | 137 |
cytotoxicity | 136 |
patterns | 136 |
rats | 135 |
deaths | 135 |
illness | 135 |
thalassemia | 134 |
syndromes | 134 |
interval | 134 |
etiology | 134 |
chart | 134 |
gain | 133 |
classification | 132 |
muscle | 132 |
signal | 131 |
p53 | 131 |
molecule | 131 |
hypothesis | 131 |
challenge | 130 |
allele | 130 |
amplification | 130 |
standard | 130 |
efficiency | 130 |
performance | 130 |
bacteremia | 129 |
survey | 127 |
processes | 127 |
probability | 127 |
immunotherapy | 127 |
decision | 127 |
malaria | 126 |
infant | 126 |
delivery | 125 |
chromosome | 125 |
approaches | 125 |
genotype | 125 |
irradiation | 125 |
toxicities | 124 |
pregnancy | 124 |
overexpression | 124 |
options | 124 |
context | 124 |
cohorts | 124 |
centre | 124 |
finding | 123 |
database | 123 |
diagnoses | 123 |
members | 123 |
measles | 123 |
repertoire | 123 |
i | 122 |
consolidation | 122 |
migration | 121 |
globulin | 121 |
gut | 121 |
microscopy | 121 |
ul | 121 |
protection | 121 |
reference | 121 |
resection | 121 |
processing | 120 |
ferritin | 120 |
example | 120 |
adenocarcinoma | 120 |
plerixafor | 119 |
observation | 119 |
influence | 119 |
complex | 118 |
bowel | 118 |
exon | 118 |
subtypes | 118 |
neuroblastoma | 118 |
macrophage | 117 |
protocols | 116 |
ebna1 | 116 |
countries | 116 |
car | 116 |
start | 115 |
phenotypes | 115 |
percent | 115 |
herpesvirus | 115 |
episode | 115 |
animal | 115 |
alterations | 115 |
biomarkers | 114 |
complement | 114 |
correlations | 114 |
diabetes | 114 |
medications | 114 |
ptcy | 113 |
contact | 113 |
clearance | 113 |
adhesion | 113 |
amount | 112 |
burden | 112 |
epitope | 112 |
repair | 111 |
mononucleosis | 111 |
immunization | 111 |
estimates | 111 |
autoantibodies | 111 |
arthritis | 111 |
fact | 110 |
tumours | 110 |
neoplasm | 110 |
splenomegaly | 109 |
pbmcs | 109 |
pathogen | 109 |
fish | 109 |
communication | 109 |
viability | 109 |
bleeding | 108 |
adenovirus | 108 |
blasts | 108 |
transduction | 108 |
providers | 108 |
trend | 108 |
girl | 107 |
ad | 107 |
delay | 107 |
diversity | 107 |
hypogammaglobulinemia | 107 |
hand | 107 |
software | 107 |
strains | 107 |
purpose | 106 |
problem | 106 |
indication | 106 |
humans | 106 |
discharge | 106 |
degradation | 106 |
ages | 105 |
mother | 105 |
melanoma | 105 |
half | 105 |
novel | 105 |
systems | 105 |
possibility | 105 |
ligands | 105 |
subset | 105 |
responders | 104 |
relation | 104 |
problems | 104 |
inclusion | 104 |
impairment | 104 |
subtype | 104 |
n=2 | 103 |
density | 103 |
epitopes | 103 |
men | 103 |
material | 103 |
persistence | 103 |
tyrosine | 103 |
technology | 103 |
thymus | 103 |
scan | 103 |
manner | 102 |
content | 102 |
sections | 102 |
signaling | 102 |
team | 101 |
strain | 101 |
pressure | 101 |
polymerase | 101 |
benefit | 101 |
asthma | 100 |
manifestation | 100 |
deficiencies | 100 |
ctls | 100 |
discussion | 100 |
⩾ | 100 |
pneumoniae | 100 |
prostate | 100 |
woman | 99 |
medium | 99 |
media | 99 |
implications | 99 |
immune | 99 |
fluorescence | 99 |
accumulation | 99 |
home | 99 |
transition | 98 |
techniques | 98 |
lungs | 98 |
excision | 98 |
immunodeficiencies | 97 |
fraction | 97 |
synthesis | 97 |
pt | 97 |
translocation | 97 |
ultrasound | 96 |
signals | 96 |
siblings | 96 |
mrna | 96 |
morphology | 96 |
characterization | 96 |
μl | 95 |
profiles | 95 |
particles | 95 |
herpes | 95 |
consent | 95 |
boy | 95 |
action | 95 |
copy | 94 |
reasons | 94 |
medication | 94 |
recruitment | 94 |
registry | 94 |
scale | 94 |
units | 94 |
yield | 94 |
way | 93 |
thyroid | 93 |
symptom | 93 |
surveillance | 93 |
histology | 93 |
cytoplasm | 93 |
blot | 93 |
interventions | 92 |
amino | 92 |
choice | 92 |
cytopenias | 92 |
fluid | 92 |
location | 92 |
ng | 92 |
obstruction | 92 |
project | 92 |
technique | 92 |
screen | 91 |
mononuclear | 91 |
goal | 91 |
dosing | 91 |
candidate | 91 |
isolation | 90 |
actin | 90 |
aspects | 90 |
domains | 90 |
# | 90 |
killer | 90 |
rash | 90 |
step | 90 |
lipid | 90 |
nature | 89 |
lymphohistiocytosis | 89 |
education | 89 |
latency | 88 |
basal | 88 |
consensus | 88 |
cross | 88 |
dialysis | 88 |
plasmid | 88 |
mm | 88 |
n=3 | 88 |
reactivity | 88 |
variability | 88 |
world | 88 |
extent | 87 |
acids | 87 |
csa | 87 |
training | 87 |
paraffin | 87 |
quantification | 87 |
varicella | 87 |
mast | 86 |
leukocyte | 86 |
elements | 86 |
alternative | 86 |
terminal | 85 |
neoplasms | 85 |
nausea | 85 |
hyperplasia | 85 |
hybridization | 85 |
evolution | 85 |
csf | 85 |
cytomegalovirus | 84 |
activities | 84 |
affinity | 84 |
image | 84 |
lymphadenopathy | 84 |
posttransplant | 84 |
search | 83 |
fatigue | 83 |
evs | 83 |
cystitis | 83 |
concern | 83 |
lupus | 82 |
challenges | 82 |
device | 82 |
immunoglobulins | 82 |
albumin | 82 |
microvesicles | 82 |
neck | 82 |
outpatient | 82 |
respect | 82 |
success | 82 |
access | 81 |
appearance | 81 |
arm | 81 |
composition | 81 |
distress | 81 |
hormone | 81 |
matrix | 81 |
mismatch | 81 |
nephropathy | 81 |
reason | 81 |
vectors | 81 |
hematuria | 80 |
catenin | 80 |
clinicians | 80 |
completion | 80 |
depression | 80 |
man | 80 |
tacrolimus | 80 |
nuclei | 80 |
risks | 80 |
sources | 80 |
measures | 80 |
structure | 79 |
localization | 79 |
gland | 79 |
diameter | 79 |
measurement | 78 |
dermatitis | 78 |
indications | 78 |
compartment | 78 |
relapses | 78 |
th1 | 78 |
staff | 78 |
member | 77 |
field | 77 |
hemorrhage | 77 |
helper | 77 |
people | 77 |
platform | 77 |
polymorphism | 77 |
stay | 77 |
suspicion | 76 |
shock | 76 |
hscs | 76 |
effectiveness | 76 |
dcs | 76 |
candidates | 76 |
dysplasia | 75 |
entity | 75 |
complexes | 75 |
radiotherapy | 75 |
admissions | 75 |
frequencies | 75 |
enzymes | 75 |
timing | 75 |
glycoprotein | 75 |
phage | 75 |
phases | 75 |
roles | 75 |
ifng | 75 |
variation | 74 |
precursor | 74 |
mucosa | 74 |
kinetics | 74 |
availability | 74 |
limitations | 73 |
abscess | 73 |
angiogenesis | 73 |
costs | 73 |
environment | 73 |
nodules | 73 |
minutes | 73 |
periods | 73 |
physicians | 73 |
rest | 73 |
structures | 73 |
yrs | 72 |
observations | 72 |
fevers | 72 |
entry | 72 |
rearrangement | 71 |
measurements | 71 |
nephritis | 71 |
oxygen | 71 |
scans | 71 |
regulator | 71 |
school | 71 |
core | 70 |
utilization | 70 |
osteosarcoma | 70 |
organisms | 70 |
lymphoproliferation | 70 |
leukocytes | 70 |
corticosteroid | 70 |
boys | 70 |
aspergillus | 70 |
granulocytes | 69 |
hematology | 69 |
rubella | 69 |
gram | 69 |
mean | 69 |
lineage | 69 |
vessels | 69 |
mm3 | 69 |
peak | 69 |
rat | 69 |
temperature | 69 |
wall | 69 |
hemolysis | 68 |
fragment | 68 |
mg/ | 68 |
autophagy | 68 |
algorithm | 68 |
incidences | 68 |
compound | 68 |
missense | 68 |
placebo | 68 |
predictors | 68 |
subunit | 68 |
transmission | 68 |
ventilation | 68 |
pids | 68 |
girls | 67 |
bronchiectasis | 67 |
colony | 67 |
courses | 67 |
delta | 67 |
eczema | 67 |
exam | 67 |
feasibility | 67 |
log | 67 |
kidneys | 67 |
progenitor | 67 |
recommendations | 67 |
situ | 67 |
subgroup | 67 |
subgroups | 67 |
titer | 67 |
upregulation | 67 |
programs | 66 |
abscesses | 66 |
mab | 66 |
means | 66 |
one | 66 |
benefits | 66 |
relevance | 66 |
stool | 66 |
traits | 66 |
workup | 66 |
β | 66 |
splenectomy | 66 |
dexamethasone | 65 |
advantage | 65 |
aureus | 65 |
contribution | 65 |
cough | 65 |
cure | 65 |
department | 65 |
categories | 65 |
father | 65 |
otitis | 65 |
parent | 65 |
rank | 65 |
repeat | 65 |
spindle | 65 |
summary | 65 |
hps | 65 |
nasal | 64 |
conversion | 64 |
enuresis | 64 |
fibroblasts | 64 |
issues | 64 |
leukaemia | 64 |
settings | 64 |
overload | 64 |
regard | 64 |
tetanus | 64 |
threshold | 64 |
thymocytes | 64 |
transfection | 64 |
cd40l | 63 |
focus | 63 |
determination | 63 |
human | 63 |
biomarker | 63 |
attention | 63 |
hd | 63 |
predictor | 63 |
ones | 63 |
specimen | 63 |
subpopulations | 63 |
vasculitis | 63 |
vein | 63 |
zoster | 63 |
glands | 62 |
blast | 62 |
curve | 62 |
decline | 62 |
elevation | 62 |
neonates | 62 |
physician | 62 |
question | 62 |
questionnaire | 62 |
smoking | 62 |
vs. | 62 |
epidemiology | 61 |
associations | 61 |
catheter | 61 |
edema | 61 |
enhancement | 61 |
tonsils | 61 |
epithelium | 61 |
locus | 61 |
microbiota | 61 |
probe | 61 |
slides | 61 |
headache | 60 |
comorbidities | 60 |
crisis | 60 |
cryopreservation | 60 |
defibrotide | 60 |
expressions | 60 |
food | 60 |
pg | 60 |
height | 60 |
ubiquitin | 60 |
polymorphisms | 60 |
questions | 60 |
set | 60 |
stability | 60 |
meningitis | 60 |
dengue | 59 |
average | 59 |
carrier | 59 |
chemokines | 59 |
consequence | 59 |
consequences | 59 |
country | 59 |
cytogenetics | 59 |
dynamics | 59 |
implementation | 59 |
investigations | 59 |
issue | 59 |
presentations | 59 |
protease | 59 |
sister | 59 |
lobe | 58 |
amounts | 58 |
barriers | 58 |
carriers | 58 |
clone | 58 |
discontinuation | 58 |
exosomes | 58 |
granulocyte | 58 |
homeostasis | 58 |
compounds | 58 |
methylation | 58 |
neoplasia | 58 |
nf | 58 |
validation | 58 |
pairs | 58 |
parasite | 58 |
position | 58 |
thrombosis | 58 |
modification | 58 |
mothers | 57 |
agreement | 57 |
community | 57 |
grades | 57 |
head | 57 |
library | 57 |
mcl | 57 |
pneumonitis | 57 |
practices | 57 |
proteasome | 57 |
sarcomas | 57 |
sirolimus | 57 |
sodium | 57 |
uptake | 57 |
utility | 57 |
metabolism | 56 |
alleles | 56 |
cleavage | 56 |
immunofluorescence | 56 |
incubation | 56 |
insufficiency | 56 |
intake | 56 |
lab | 56 |
fertility | 56 |
modulation | 56 |
preparation | 56 |
room | 56 |
tomography | 56 |
tools | 56 |
transcripts | 56 |
vomiting | 56 |
pancreas | 56 |
functioning | 55 |
airway | 55 |
behavior | 55 |
efs | 55 |
fellows | 55 |
malformations | 55 |
restriction | 55 |
sessions | 55 |
stroke | 55 |
decades | 54 |
8) | 54 |
agonist | 54 |
apcs | 54 |
biology | 54 |
caregivers | 54 |
cavity | 54 |
consideration | 54 |
cysts | 54 |
layer | 54 |
fragments | 54 |
place | 54 |
immunogenicity | 54 |
signature | 54 |
rabbit | 54 |
title | 54 |
modalities | 54 |
journal | 54 |
instability | 54 |
intervals | 53 |
cd45ra | 53 |
collagen | 53 |
confidence | 53 |
counseling | 53 |
heterogeneity | 53 |
hospitalizations | 53 |
immunology | 53 |
transplantations | 53 |
light | 53 |
serology | 53 |
water | 53 |
trait | 53 |
lysis | 53 |
schedule | 53 |
pid | 53 |
mitogen | 53 |
mediators | 52 |
+100 | 52 |
adv | 52 |
electron | 52 |
farm | 52 |
foci | 52 |
genotypes | 52 |
insights | 52 |
masses | 52 |
microarray | 52 |
normalization | 52 |
nucleus | 52 |
percentile | 52 |
pool | 52 |
rag | 52 |
terminus | 52 |
version | 52 |
vesicles | 52 |
increases | 51 |
concerns | 51 |
cord_uid | 51 |
dock8 | 51 |
enrichment | 51 |
era | 51 |
granulomas | 51 |
institutions | 51 |
killing | 51 |
kinases | 51 |
needs | 51 |
persons | 51 |
purpura | 51 |
suppressor | 51 |
brother | 50 |
injections | 50 |
emergency | 50 |
defense | 50 |
allergy | 50 |
base | 50 |
barrier | 50 |
anxiety | 50 |
mmf | 50 |
microenvironment | 50 |
needle | 50 |
subject | 50 |
ulcers | 50 |
picture | 50 |
prediction | 50 |
progress | 50 |
ray | 50 |
record | 50 |
stains | 50 |
statistics | 50 |
nutrition | 50 |
supplementation | 50 |
diet | 49 |
deposition | 49 |
grading | 49 |
coronavirus | 49 |
cidofovir | 49 |
cholesterol | 49 |
discovery | 49 |
pathophysiology | 49 |
immunophenotype | 49 |
karyotype | 49 |
mutants | 49 |
placement | 49 |
qol | 49 |
sinusitis | 49 |
infiltrate | 49 |
face | 48 |
improvements | 48 |
hematopoiesis | 48 |
healthcare | 48 |
healing | 48 |
flu | 48 |
enrollment | 48 |
exchange | 48 |
interpretation | 48 |
cxcr4 | 48 |
coagulation | 48 |
advances | 48 |
incompatibility | 48 |
establishment | 48 |
intestine | 48 |
rescue | 48 |
nkg2d | 48 |
switch | 48 |
stimuli | 48 |
retrovirus | 48 |
resources | 48 |
ring | 48 |
rearrangements | 48 |
plate | 48 |
phosphatase | 48 |
phagocytosis | 48 |
osteomyelitis | 48 |
organism | 48 |
mouth | 47 |
alteration | 47 |
clusters | 47 |
description | 47 |
documentation | 47 |
eculizumab | 47 |
feature | 47 |
mode | 47 |
pc | 47 |
newborns | 47 |
phenotyping | 47 |
precursors | 47 |
steps | 47 |
strength | 47 |
tolerability | 47 |
usage | 47 |
norm | 47 |
decade | 46 |
removal | 46 |
neutralization | 46 |
eosinophils | 46 |
route | 46 |
coli | 46 |
chemokine | 46 |
accuracy | 46 |
rise | 46 |
modality | 46 |
section | 46 |
sinus | 46 |
tube | 46 |
solution | 46 |
spp | 46 |
stat1 | 46 |
stroma | 46 |
supernatants | 46 |
simplex | 46 |
deletions | 45 |
erythematosus | 45 |
eosinophilia | 45 |
downregulation | 45 |
dosage | 45 |
abdomen | 45 |
cut | 45 |
confirmation | 45 |
category | 45 |
awareness | 45 |
infectivity | 45 |
hemophilia | 45 |
approval | 45 |
loci | 45 |
splice | 45 |
trecs | 45 |
n=9 | 45 |
transport | 45 |
substrates | 45 |
trigger | 45 |
residues | 45 |
referral | 45 |
progenitors | 45 |
participation | 45 |
output | 45 |
aspiration | 44 |
chromatin | 44 |
colonization | 44 |
consumption | 44 |
effusion | 44 |
endpoint | 44 |
formalin | 44 |
gradient | 44 |
images | 44 |
link | 44 |
plasmids | 44 |
recombination | 44 |
reporter | 44 |
resonance | 44 |
seizures | 44 |
supernatant | 44 |
zone | 44 |
panels | 44 |
cadherin | 43 |
engagement | 43 |
elimination | 43 |
concept | 43 |
complexity | 43 |
candidiasis | 43 |
assessments | 43 |
bilirubin | 43 |
balance | 43 |
atm | 43 |
aggregation | 43 |
exclusion | 43 |
errors | 43 |
buffer | 43 |
fluconazole | 43 |
swelling | 43 |
infancy | 43 |
requirement | 43 |
predisposition | 43 |
phenomenon | 43 |
mellitus | 43 |
provider | 43 |
medicine | 43 |
match | 43 |
malnutrition | 43 |
luciferase | 43 |
label | 43 |
illnesses | 42 |
abundance | 42 |
ascites | 42 |
aspergillosis | 42 |
bal | 42 |
demographics | 42 |
dissemination | 42 |
fungi | 42 |
future | 42 |
hair | 42 |
il-2 | 42 |
subpopulation | 42 |
sampling | 42 |
lysates | 42 |
survivin | 42 |
staging | 42 |
γ | 42 |
primers | 42 |
n=8 | 42 |
mycobacteria | 42 |
milk | 42 |
fibrinogen | 41 |
intolerance | 41 |
inability | 41 |
hazard | 41 |
genetics | 41 |
gel | 41 |
note | 41 |
art | 41 |
extraction | 41 |
cytology | 41 |
centres | 41 |
artery | 41 |
arrest | 41 |
anomalies | 41 |
nerve | 41 |
resource | 41 |
pcr | 41 |
situation | 41 |
pi | 41 |
visits | 41 |
visit | 41 |
transcript | 41 |
substitution | 41 |
tendency | 41 |
relationships | 41 |
reflux | 41 |
proportions | 41 |
predominance | 41 |
pneumonias | 41 |
plates | 41 |
efforts | 40 |
interference | 40 |
glucose | 40 |
materials | 40 |
fractions | 40 |
extension | 40 |
exercise | 40 |
amyloidosis | 40 |
destruction | 40 |
depth | 40 |
combinations | 40 |
cisplatin | 40 |
cellularity | 40 |
block | 40 |
adjuvant | 40 |
isolates | 40 |
prednisone | 40 |
measure | 40 |
shrna | 40 |
mucositis | 40 |
weakness | 40 |
turn | 40 |
testis | 40 |
subunits | 40 |
signalling | 40 |
variations | 40 |
salivary | 40 |
requirements | 40 |
reactivations | 40 |
questionnaires | 40 |
pr | 40 |
parasites | 40 |
respondents | 40 |
difficulties | 39 |
egfr | 39 |
duct | 39 |
donation | 39 |
disability | 39 |
anticoagulation | 39 |
concordance | 39 |
cdna | 39 |
bleomycin | 39 |
agonists | 39 |
evaluations | 39 |
entities | 39 |
genomes | 39 |
uric | 39 |
interviews | 39 |
limit | 39 |
membranes | 39 |
nodule | 39 |
pathogenicity | 39 |
restoration | 39 |
sd | 39 |
tonsillectomy | 39 |
volunteers | 39 |
wound | 39 |
glomerulonephritis | 39 |
ex | 38 |
definition | 38 |
endoscopy | 38 |
hosts | 38 |
extremities | 38 |
eyes | 38 |
compartments | 38 |
cytoskeleton | 38 |
atypia | 38 |
comorbidity | 38 |
collections | 38 |
chemo | 38 |
bodies | 38 |
applications | 38 |
adenomas | 38 |
hearing | 38 |
codon | 38 |
hpv | 38 |
oxidase | 38 |
inactivation | 38 |
μg | 38 |
throat | 38 |
stomach | 38 |
quantity | 38 |
percentages | 38 |
ultrasonography | 38 |
nk | 38 |
nephrectomy | 38 |
n=7 | 38 |
matching | 38 |
lad | 38 |
insertion | 38 |
network | 38 |
fungal | 37 |
ist | 37 |
igm | 37 |
hypotension | 37 |
harvest | 37 |
caspase | 37 |
derivatives | 37 |
decisions | 37 |
coagulopathy | 37 |
activator | 37 |
nurses | 37 |
manuscript | 37 |
app | 37 |
pet | 37 |
storage | 37 |
pre | 37 |
warts | 37 |
third | 37 |
submission | 37 |
trough | 37 |
stain | 37 |
stabilization | 37 |
smears | 37 |
service | 37 |
sct | 37 |
erythrocyte | 36 |
account | 36 |
adenocarcinomas | 36 |
atrophy | 36 |
beam | 36 |
capture | 36 |
editing | 36 |
emergence | 36 |
enterovirus | 36 |
chains | 36 |
existence | 36 |
hypoxia | 36 |
insight | 36 |
podocytes | 36 |
priming | 36 |
profiling | 36 |
splicing | 36 |
tnfa | 36 |
falciparum | 36 |
flag | 35 |
feedback | 35 |
filter | 35 |
hemodialysis | 35 |
fluids | 35 |
formula | 35 |
heat | 35 |
experiences | 35 |
eye | 35 |
cyst | 35 |
envelope | 35 |
electrophoresis | 35 |
devices | 35 |
cutoff | 35 |
coefficient | 35 |
blinatumomab | 35 |
beginning | 35 |
hour | 35 |
hospitals | 35 |
stratification | 35 |
hsv-1 | 35 |
person | 35 |
insulin | 35 |
wk | 35 |
spine | 35 |
shift | 35 |
saline | 35 |
plan | 35 |
pigs | 35 |
photopheresis | 35 |
toxoplasmosis | 35 |
pair | 35 |
oxide | 35 |
organization | 35 |
methylprednisolone | 35 |
loading | 35 |
leukapheresis | 35 |
labs | 35 |
pad | 35 |
burst | 34 |
extremity | 34 |
extract | 34 |
element | 34 |
degrees | 34 |
compliance | 34 |
cd3 | 34 |
c3 | 34 |
arms | 34 |
blocks | 34 |
atopy | 34 |
array | 34 |
amphotericin | 34 |
adenoma | 34 |
abnormality | 34 |
granules | 34 |
foot | 34 |
herpesviruses | 34 |
withdrawal | 34 |
preservation | 34 |
histone | 34 |
volumes | 34 |
view | 34 |
trends | 34 |
trauma | 34 |
serotypes | 34 |
segment | 34 |
smear | 34 |
pathologists | 34 |
immunoreactivity | 34 |
matter | 34 |
hscts | 34 |
immunophenotyping | 34 |
homology | 34 |
isoforms | 34 |
manufacturing | 34 |
drainage | 33 |
frame | 33 |
formulation | 33 |
excretion | 33 |
erythrocytes | 33 |
enlargement | 33 |
endpoints | 33 |
encephalopathy | 33 |
encephalomyelitis | 33 |
help | 33 |
doxorubicin | 33 |
conflicts | 33 |
assembly | 33 |
anti | 33 |
alloreactivity | 33 |
agammaglobulinemia | 33 |
adaptor | 33 |
1a | 33 |
h. | 33 |
typing | 33 |
ice | 33 |
regeneration | 33 |
ii | 33 |
weekly | 33 |
variance | 33 |
transgene | 33 |
situations | 33 |
saliva | 33 |
retention | 33 |
regulators | 33 |
separation | 33 |
non | 33 |
laboratories | 33 |
nm | 33 |
keratinocytes | 33 |
kits | 33 |
imatinib | 33 |
latent | 33 |
lfs | 33 |
lineages | 32 |
disruption | 32 |
knockdown | 32 |
jaundice | 32 |
guidance | 32 |
glycosylation | 32 |
foxp3 | 32 |
fluorescent | 32 |
experiment | 32 |
exons | 32 |
accordance | 32 |
differential | 32 |
desensitization | 32 |
demyelination | 32 |
curves | 32 |
contamination | 32 |
chronic | 32 |
centrifugation | 32 |
cd | 32 |
mobilizers | 32 |
microscope | 32 |
costimulatory | 32 |
modifications | 32 |
pulse | 32 |
moment | 32 |
vessel | 32 |
uv | 32 |
slope | 32 |
sequelae | 32 |
™ | 32 |
reproducibility | 32 |
rationale | 32 |
ranges | 32 |
vaccinations | 32 |
probes | 32 |
parallel | 32 |
pretreatment | 32 |
opportunity | 32 |
pancreatitis | 32 |
outbreaks | 32 |
partners | 32 |
parvovirus | 32 |
polyps | 32 |
power | 32 |
integrity | 31 |
details | 31 |
income | 31 |
heparin | 31 |
ganciclovir | 31 |
feeding | 31 |
error | 31 |
effusions | 31 |
display | 31 |
calcineurin | 31 |
detail | 31 |
der | 31 |
chelation | 31 |
cc | 31 |
boost | 31 |
author | 31 |
attempt | 31 |
ischemia | 31 |
interleukin | 31 |
n=1 | 31 |
lavage | 31 |
satisfaction | 31 |
α | 31 |
loads | 31 |
spread | 31 |
spots | 31 |
space | 31 |
sows | 31 |
sorting | 31 |
sign | 31 |
toll | 31 |
rr | 31 |
pilot | 31 |
phagocytes | 31 |
pca | 31 |
parts | 31 |
pandemic | 31 |
negativity | 31 |
retroviruses | 31 |
clinician | 30 |
fat | 30 |
evasion | 30 |
deposits | 30 |
grant | 30 |
databases | 30 |
ctla-4 | 30 |
criterion | 30 |
blockade | 30 |
charts | 30 |
channels | 30 |
chance | 30 |
autoantibody | 30 |
attempts | 30 |
anaemia | 30 |
/kg | 30 |
+ | 30 |
funding | 30 |
individual | 30 |
guideline | 30 |
oncogene | 30 |
histopathology | 30 |
wt | 30 |
thickness | 30 |
potency | 30 |
placentas | 30 |
paucity | 30 |
optimization | 30 |
race | 30 |
nets | 30 |
mo | 30 |
making | 30 |
limits | 30 |
hypersensitivity | 30 |
incorporation | 30 |
i. | 30 |
myocarditis | 30 |
characteristic | 29 |
escape | 29 |
cytometric | 29 |
correction | 29 |
cluster | 29 |
bloodstream | 29 |
catheters | 29 |
cascade | 29 |
bronchiolitis | 29 |
behaviour | 29 |
atherosclerosis | 29 |
galcer | 29 |
examinations | 29 |
estrogen | 29 |
haploinsufficiency | 29 |
spot | 29 |
house | 29 |
vd2 | 29 |
testosterone | 29 |
telomere | 29 |
students | 29 |
tubules | 29 |
sequestration | 29 |
parameter | 29 |
mitochondria | 29 |
major | 29 |
scheme | 29 |
implantation | 29 |
explanation | 28 |
dilution | 28 |
duplication | 28 |
ear | 28 |
etiologies | 28 |
feet | 28 |
exposures | 28 |
fractures | 28 |
glomeruli | 28 |
deficits | 28 |
difficulty | 28 |
bones | 28 |
dataset | 28 |
curriculum | 28 |
chip | 28 |
carcinogenesis | 28 |
bx1 | 28 |
bridge | 28 |
blots | 28 |
anaphylaxis | 28 |
alveolar | 28 |
adulthood | 28 |
functionality | 28 |
hypoplasia | 28 |
gold | 28 |
phosphate | 28 |
hydroxyurea | 28 |
vsts | 28 |
vimentin | 28 |
transcriptase | 28 |
thawing | 28 |
suspension | 28 |
scar | 28 |
rapamycin | 28 |
pools | 28 |
polysaccharide | 28 |
therapeutics | 28 |
party | 28 |
lymphopenia | 28 |
odds | 28 |
indicators | 28 |
ligation | 28 |
ltx | 28 |
mantle | 28 |
metabolites | 28 |
micrornas | 28 |
motif | 28 |
inheritance | 27 |
dehydrogenase | 27 |
ifnγ | 27 |
fumigatus | 27 |
files | 27 |
effort | 27 |
diphtheria | 27 |
basophils | 27 |
d1 | 27 |
coverage | 27 |
constipation | 27 |
blotting | 27 |
b1 | 27 |
antibiotic | 27 |
margins | 27 |
list | 27 |
manufacturer | 27 |
obesity | 27 |
states | 27 |
≤ | 27 |
translation | 27 |
thyroiditis | 27 |
thickening | 27 |
synapse | 27 |
stromal | 27 |
stature | 27 |
throughput | 27 |
similarities | 27 |
residents | 27 |
relatives | 27 |
recurrences | 27 |
overlap | 27 |
oncologists | 27 |
scoring | 27 |
joints | 26 |
grants | 26 |
gvl | 26 |
il-1b | 26 |
influenzae | 26 |
liquid | 26 |
leptin | 26 |
libraries | 26 |
likelihood | 26 |
locations | 26 |
exception | 26 |
figures | 26 |
beads | 26 |
eligibility | 26 |
deterioration | 26 |
degeneration | 26 |
dasatinib | 26 |
cytarabine | 26 |
computer | 26 |
booster | 26 |
mapping | 26 |
backbone | 26 |
antagonist | 26 |
advantages | 26 |
lymphoblastoid | 26 |
repertoires | 26 |
mesothelioma | 26 |
responder | 26 |
virions | 26 |
microbiome | 26 |
variable | 26 |
update | 26 |
thymocyte | 26 |
targeting | 26 |
tail | 26 |
sets | 26 |
serotherapy | 26 |
seizure | 26 |
responsiveness | 26 |
streptococcus | 26 |
paper | 26 |
pylori | 26 |
puberty | 26 |
psoriasis | 26 |
preference | 26 |
polarization | 26 |
minimum | 26 |
p=0.02 | 26 |
ova | 26 |
motion | 26 |
reading | 26 |
failures | 25 |
filtration | 25 |
immunizations | 25 |
experts | 25 |
estimation | 25 |
fold | 25 |
glioma | 25 |
followup | 25 |
gastritis | 25 |
gastroenteritis | 25 |
germ | 25 |
granule | 25 |
env | 25 |
epidermis | 25 |
aspirate | 25 |
endothelium | 25 |
disappearance | 25 |
degranulation | 25 |
deafness | 25 |
crp | 25 |
conjugate | 25 |
colonies | 25 |
chromosomes | 25 |
cellulitis | 25 |
carcinoid | 25 |
axis | 25 |
appendix | 25 |
allohsct | 25 |
accessibility | 25 |
integration | 25 |
indicator | 25 |
neuropathy | 25 |
knee | 25 |
reperfusion | 25 |
users | 25 |
travel | 25 |
topic | 25 |
tecs | 25 |
surveys | 25 |
substrate | 25 |
sub | 25 |
standards | 25 |
skills | 25 |
shingles | 25 |
reviews | 25 |
residue | 25 |
reservoir | 25 |
zinc | 25 |
rarity | 25 |
mutant | 25 |
pta | 25 |
leg | 25 |
letermovir | 25 |
monotherapy | 25 |
morbidities | 25 |
motor | 25 |
knockout | 25 |
nanoparticles | 25 |
opportunities | 25 |
pelvis | 25 |
pharyngitis | 25 |
night | 25 |
prednisolone | 25 |
encoding | 24 |
duodenum | 24 |
electroporation | 24 |
elevations | 24 |
emphasis | 24 |
exosome | 24 |
ethnicity | 24 |
distinction | 24 |
fibroblast | 24 |
gestation | 24 |
glomerulosclerosis | 24 |
goals | 24 |
hands | 24 |
division | 24 |
contacts | 24 |
difficile | 24 |
dependence | 24 |
complaints | 24 |
comparisons | 24 |
color | 24 |
codes | 24 |
circulation | 24 |
chitosan | 24 |
arteries | 24 |
antifungal | 24 |
amyloid | 24 |
allografts | 24 |
albicans | 24 |
hypothyroidism | 24 |
cocktail | 24 |
integrin | 24 |
immunosuppressants | 24 |
pathologies | 24 |
isoform | 24 |
tree | 24 |
toxoplasma | 24 |
tonsillitis | 24 |
text | 24 |
stomatitis | 24 |
sense | 24 |
scanning | 24 |
rnas | 24 |
rhinovirus | 24 |
rheumatoid | 24 |
ratios | 24 |
rafts | 24 |
university | 24 |
past | 24 |
mitoses | 24 |
laser | 24 |
leukocytosis | 24 |
losses | 24 |
microorganisms | 24 |
mismatches | 24 |
manipulation | 24 |
mixture | 24 |
mobilisation | 24 |
mod | 24 |
myelin | 24 |
myopathy | 24 |
parenchyma | 24 |
glycoproteins | 23 |
fate | 23 |
follicle | 23 |
follicles | 23 |
frameshift | 23 |
germline | 23 |
kind | 23 |
granzyme | 23 |
igg4 | 23 |
influx | 23 |
ip | 23 |
key | 23 |
energy | 23 |
fashion | 23 |
collaboration | 23 |
encounters | 23 |
diagnostics | 23 |
cyclin | 23 |
cullins | 23 |
consultation | 23 |
conjugates | 23 |
candida | 23 |
antisense | 23 |
adjustment | 23 |
adenoids | 23 |
additive | 23 |
+4 | 23 |
loop | 23 |
lectin | 23 |
nose | 23 |
methodology | 23 |
portion | 23 |
n=4 | 23 |
wildtype | 23 |
wells | 23 |
valve | 23 |
topics | 23 |
spite | 23 |
remissions | 23 |
relative | 23 |
refractory | 23 |
puncture | 23 |
pump | 23 |
pos | 23 |
tandem | 23 |
policy | 23 |
offspring | 23 |
plaques | 23 |
nitric | 23 |
yr | 23 |
nurse | 23 |
o0.05 | 23 |
nursing | 23 |
papilloma | 23 |
parenchymal | 23 |
perforation | 23 |
pharmacy | 23 |
plaque | 23 |
cytopenia | 22 |
hemophagocytosis | 22 |
cytosol | 22 |
dl. | 22 |
embryo | 22 |
estimate | 22 |
fibers | 22 |
haplotype | 22 |
internalization | 22 |
hepatotoxicity | 22 |
histiocytosis | 22 |
honoraria | 22 |
hypertrophy | 22 |
instances | 22 |
instructions | 22 |
liposome | 22 |
contents | 22 |
cyto | 22 |
allergens | 22 |
considerations | 22 |
aspect | 22 |
24h | 22 |
absorption | 22 |
aggregates | 22 |
allergen | 22 |
margin | 22 |
alt | 22 |
anesthesia | 22 |
attacks | 22 |
connection | 22 |
autopsy | 22 |
avidity | 22 |
cardiomyopathy | 22 |
cart | 22 |
charge | 22 |
chemotaxis | 22 |
chl | 22 |
malaise | 22 |
labeling | 22 |
mcg | 22 |
repression | 22 |
services | 22 |
sleep | 22 |
slide | 22 |
spectrometry | 22 |
sputum | 22 |
stop | 22 |
tnf | 22 |
tongue | 22 |
transmembrane | 22 |
transporter | 22 |
turnover | 22 |
urinalysis | 22 |
usefulness | 22 |
mediator | 22 |
vaccinia | 22 |
velocities | 22 |
vod | 22 |
return | 22 |
v3 | 22 |
reagent | 22 |
perspectives | 22 |
rashes | 22 |
mobility | 22 |
neurons | 22 |
nonsense | 22 |
op | 22 |
osteoporosis | 22 |
papillomavirus | 22 |
mitosis | 22 |
posttransplantation | 22 |
pregnancies | 22 |
preparations | 22 |
proof | 22 |
purposes | 22 |
precision | 22 |
radiosensitivity | 22 |
erythroid | 21 |
digestion | 21 |
dimension | 21 |
enterocolitis | 21 |
enumeration | 21 |
epidemic | 21 |
erythema | 21 |
facility | 21 |
exacerbation | 21 |
exhaustion | 21 |
fellowship | 21 |
foxn1 | 21 |
gallbladder | 21 |
graftversus | 21 |
consanguinity | 21 |
cooperation | 21 |
bank | 21 |
conjunction | 21 |
clinico | 21 |
cirrhosis | 21 |
circles | 21 |
bronchoscopy | 21 |
bronchitis | 21 |
bias | 21 |
antagonists | 21 |
amos | 21 |
allopurinol | 21 |
algorithms | 21 |
aes | 21 |
adolescence | 21 |
-1 | 21 |
histamine | 21 |
hematocrit | 21 |
hallmark | 21 |
immunoprecipitation | 21 |
signet | 21 |
readmission | 21 |
reinduction | 21 |
remodeling | 21 |
retardation | 21 |
rna | 21 |
ruxolitinib | 21 |
stimulus | 21 |
pbmc | 21 |
survivorship | 21 |
tap | 21 |
threat | 21 |
tubes | 21 |
urticaria | 21 |
vctl | 21 |
pcs | 21 |
saturation | 21 |
particle | 21 |
lymphoblasts | 21 |
oligonucleotides | 21 |
infertility | 21 |
institute | 21 |
insurance | 21 |
investigators | 21 |
ligase | 21 |
lenalidomide | 21 |
lysate | 21 |
machinery | 21 |
maximum | 21 |
meeting | 21 |
melphalan | 21 |
mumps | 21 |
encephalitis | 20 |
gliomas | 20 |
ev | 20 |
examples | 20 |
finger | 20 |
foscarnet | 20 |
gag | 20 |
glass | 20 |
instance | 20 |
gp | 20 |
granuloma | 20 |
hepatocytes | 20 |
hip | 20 |
ibrutinib | 20 |
imbalance | 20 |
immortalization | 20 |
disturbances | 20 |
echocardiogram | 20 |
alemtuzumab | 20 |
determinants | 20 |
descent | 20 |
aims | 20 |
legs | 20 |
analogs | 20 |
astrocytes | 20 |
attenuation | 20 |
bacilli | 20 |
basement | 20 |
bile | 20 |
bm | 20 |
buds | 20 |
bystander | 20 |
capsule | 20 |
chromatography | 20 |
colonoscopy | 20 |
dermis | 20 |
instrument | 20 |
isotype | 20 |
today | 20 |
supply | 20 |
reverse | 20 |
rhinitis | 20 |
scales | 20 |
scr | 20 |
serotype | 20 |
sin | 20 |
specialists | 20 |
synthase | 20 |
property | 20 |
tbf | 20 |
teenagers | 20 |
thiotepa | 20 |
titres | 20 |
leukemias | 20 |
vlps | 20 |
washing | 20 |
resident | 20 |
silencing | 20 |
probabilities | 20 |
o0.01 | 20 |
leukopenia | 20 |
present | 20 |
ligases | 20 |
metaplasia | 20 |
microliter | 20 |
ml. | 20 |
mncs | 20 |
leukoplakia | 20 |
oligomers | 20 |
p16 | 20 |
pap | 20 |
phlebotomy | 20 |
pi3 | 20 |
plcg2 | 20 |
operation | 20 |
dyspnea | 19 |
cysteine | 19 |
daughter | 19 |
dilatation | 19 |
dmsa | 19 |
drop | 19 |
ducts | 19 |
glucocorticoids | 19 |
episome | 19 |
front | 19 |
gcs | 19 |
hope | 19 |
hrs | 19 |
igg1 | 19 |
contrary | 19 |
ctcs | 19 |
lactate | 19 |
construction | 19 |
board | 19 |
achievement | 19 |
acquisition | 19 |
asct | 19 |
biogenesis | 19 |
bmd | 19 |
bmscs | 19 |
budding | 19 |
cloning | 19 |
cardiology | 19 |
caregiver | 19 |
cd8 | 19 |
cgy | 19 |
checkpoint | 19 |
classes | 19 |
immunologists | 19 |
regards | 19 |
layers | 19 |
stools | 19 |
γδ | 19 |
remainder | 19 |
screens | 19 |
serostatus | 19 |
smokers | 19 |
snps | 19 |
technologies | 19 |
purity | 19 |
translocations | 19 |
veins | 19 |
vincristine | 19 |
voxelotor | 19 |
ways | 19 |
lead | 19 |
qpcr | 19 |
subclass | 19 |
propensity | 19 |
norovirus | 19 |
plans | 19 |
microglia | 19 |
minority | 19 |
mir | 19 |
nests | 19 |
nfkb1 | 19 |
myelofibrosis | 19 |
osteonecrosis | 19 |
papillomatosis | 19 |
pbscs | 19 |
penicillin | 19 |